New treatment options and emerging drugs for axial spondyloarthritis: biological and targeted synthetic agents-Reference-Cited by-同舟云学术

New treatment options and emerging drugs for axial spondyloarthritis: biological and targeted synthetic agents

Author:

Toussirot Eric¹²³⁴

Affiliation:

1. INSERM CIC-1431, University Hospital of Besançon, Clinical Investigation Center in Biotherapy, Besançon, France

2. Fédération Hospitalo-Universitaire INCREASE, University Hospital of Besançon, Besançon, France

3. Department of Rheumatology, University Hospital of Besançon, Besançon, France

4. Department of Therapeutics and UPRES EA 4266: ‘Pathogenic agents and Inflammation’, University of Bourgogne Franche-Comté, Besançon, France

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

Reference66 articles.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microorganisms in the Pathogenesis and Management of Spondyloarthritis;Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases;2022

4. Ankylosing Spondylitis and Other Seronegative Arthritis;Connective Tissue Disease - Current State of the Art;2020-09-16